ATE82854T1 - Knochengezielte inhibitoren der karbonischen anhydrase. - Google Patents

Knochengezielte inhibitoren der karbonischen anhydrase.

Info

Publication number
ATE82854T1
ATE82854T1 AT86106031T AT86106031T ATE82854T1 AT E82854 T1 ATE82854 T1 AT E82854T1 AT 86106031 T AT86106031 T AT 86106031T AT 86106031 T AT86106031 T AT 86106031T AT E82854 T1 ATE82854 T1 AT E82854T1
Authority
AT
Austria
Prior art keywords
bone
carbonic anhydrase
anhydrase inhibitors
prophylaxis
inhibitor
Prior art date
Application number
AT86106031T
Other languages
English (en)
Inventor
William M Pierce Jr
Leonard C Waite
Original Assignee
Res Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Res Corp Technologies Inc filed Critical Res Corp Technologies Inc
Application granted granted Critical
Publication of ATE82854T1 publication Critical patent/ATE82854T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86106031T 1985-05-02 1986-05-02 Knochengezielte inhibitoren der karbonischen anhydrase. ATE82854T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73087385A 1985-05-02 1985-05-02
EP86106031A EP0201057B1 (de) 1985-05-02 1986-05-02 Knochengezielte Inhibitoren der karbonischen Anhydrase

Publications (1)

Publication Number Publication Date
ATE82854T1 true ATE82854T1 (de) 1992-12-15

Family

ID=24937140

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86106031T ATE82854T1 (de) 1985-05-02 1986-05-02 Knochengezielte inhibitoren der karbonischen anhydrase.

Country Status (10)

Country Link
EP (1) EP0201057B1 (de)
JP (1) JP2578098B2 (de)
AT (1) ATE82854T1 (de)
DE (1) DE3687181T2 (de)
DK (1) DK201486A (de)
ES (1) ES8802468A1 (de)
GR (1) GR861167B (de)
IE (1) IE59801B1 (de)
IL (1) IL78661A (de)
PT (1) PT82499B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0341961A3 (de) * 1988-05-09 1990-06-20 Merck & Co. Inc. Polymalonsäuren als Knochenaffinitätsagent
JPH0778024B2 (ja) * 1988-10-14 1995-08-23 藤沢薬品工業株式会社 医薬化合物とジホスホン酸誘導体の結合体を含有する医薬用製剤
US4990523A (en) * 1989-06-19 1991-02-05 A. H. Robins Company, Incorporated Treatment of chronic inflammatory joint disease with arylsulfonamides
EP0496520A1 (de) * 1991-01-22 1992-07-29 Merck & Co. Inc. Knochenaktive Verbindungen
US5183815A (en) * 1991-01-22 1993-02-02 Merck & Co., Inc. Bone acting agents
WO1994021667A1 (fr) * 1993-03-25 1994-09-29 Iskra Industry Co., Ltd. Compose inhibant la resorption osseuse et accelerant l'osteogenese
RU2136275C1 (ru) * 1993-12-29 1999-09-10 Искра Индастри Ко., Лтд. Фармацевтическая композиция, ингибирующая костную резорбцию или промотирующая остеогенез
US5880111A (en) * 1995-06-07 1999-03-09 Farcasiu; Dan Therapeutic derivations of diphosphonates
AU750451B2 (en) 1997-02-13 2002-07-18 Bone Care International, Inc. Targeted therapeutic delivery of vitamin D compounds
DE19828068C2 (de) * 1998-06-24 2003-12-18 Peter Dietsch Mittel zur spezifischen Hemmung osteoklastärer Knochenresorption
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
WO2000066613A1 (en) * 1999-04-30 2000-11-09 Research Corporation Technologies, Inc. Bone targeting agents for osteoporosis
US6436386B1 (en) * 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666897A (en) * 1983-12-29 1987-05-19 Research Foundation Of State University Inhibition of mammalian collagenolytic enzymes by tetracyclines
US4704383A (en) * 1983-12-29 1987-11-03 The Research Foundation Of State University Of New York Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same
EP0381296B1 (de) * 1984-04-30 1994-11-30 THE PROCTER & GAMBLE COMPANY Ausrüstung für die Verwendung bei der Behandlung von Osteoporose

Also Published As

Publication number Publication date
JP2578098B2 (ja) 1997-02-05
DK201486A (da) 1986-11-04
DK201486D0 (da) 1986-05-01
IL78661A (en) 1992-08-18
EP0201057B1 (de) 1992-12-02
DE3687181T2 (de) 1993-04-15
IE59801B1 (en) 1994-04-06
IL78661A0 (en) 1986-08-31
PT82499A (en) 1986-06-01
EP0201057A3 (en) 1989-10-18
IE861148L (en) 1986-11-02
ES8802468A1 (es) 1988-07-16
ES555118A0 (es) 1988-07-16
EP0201057A2 (de) 1986-11-12
GR861167B (en) 1986-09-30
DE3687181D1 (de) 1993-01-14
PT82499B (pt) 1988-10-14
JPS6226256A (ja) 1987-02-04

Similar Documents

Publication Publication Date Title
DE3687181D1 (de) Knochengezielte inhibitoren der karbonischen anhydrase.
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
ATE81457T1 (de) Arylamido (und arylthioamido)-azabicycloalkane zur steigerung des erinnerungsvermoegens oder zur behebung von gedaechtnisschwaeche.
PL288201A1 (en) Method of obtaining novel derivatives of amino acide
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
AU6567086A (en) Compositions and methods for the treatment of bleeding disorders
MY115662A (en) Novel compounds with analgesic effect
NZ218170A (en) Piperidine derivatives and pharmaceutical compositions
GB9109972D0 (en) Therapeutic compounds
HUT52376A (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient
HUT52377A (en) Process for producing pharmaceutical compositions comprising 3-substituted-2-oxindole-1-carboxamide derivatives as active ingredient
IL111580A (en) Use of melatonin derivatives in the preparation of pharmaceutical compositions for use in treating sleep disorders
HU893127D0 (en) Process for the preparation of novel spiro-(imidazolidino-naphtaline) derivatives and pharmaceutical compositions containing such compounds as active ingredient
HUT50821A (en) Process for producing new ester derivatives of acyclovir and pharmaceutical compositions comprising such compound
NO166282C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt kalsium-9-etyl-6,9-dihydro-4,6-diokso-10-propyl-4h-(3,2-g)-kinolin-2,8-di-karboksylat.
AU567018B2 (en) Prazosin-pirbuterol combination for bronchoduation
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
AU5226986A (en) 1,2,5-thiadiazol derivatives-mono or di sulphur oxides
NO913685L (no) Fremgangsmaate for fremstilling av kalsiumopptaksinhibitorer.
IT1187743B (it) Composizioni farmaceutiche a base di destrorfano per applicazione instranasale
EP0202084A3 (de) Fluoralkanderivate

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee